Back

Effects of personalized therapy-effect predictions on statin treatment decisions by patients and physicians: a three-armed, blinded, randomized controlled trial

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Lipids Secondary Prevention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Ms Nicole Elise Maria Jaspers

University Medical Center Utrecht, Utrecht (Netherlands (The))

14 More presentations in this session

Presentation thumbnail
Professor E. Bruckert (Paris, FR)
Abstract Slides
Presentation thumbnail
Doctor A. Endo (Izumo, JP)
Abstract
Presentation thumbnail
Professor I. Ahrens (Cologne, DE)
Abstract
Presentation thumbnail
Doctor O. Kobo (Hadera, IL)
Abstract Slides
Presentation thumbnail
Professor K. Sung (Seoul, KR)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Lipids

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Predicted lifetime therapy benefit guided treatment effectively reduces residual cardiovascular risk in patients with symptomatic atherosclerotic disease
29 August 2020
thumbnail
Congress Presentation
Digitally supported shared decision-making for exercise prescription in the secondary prevention of cardiovascular disease
3 April 2025
thumbnail
Congress Presentation
Association between personalized evidence-based anticoagulation therapy and outcomes at 1-year follow-up in patients with atrial fibrillation: an analysis from the Atrial Fibrillation Registry
29 June 2021
thumbnail
Congress Session
Managing cardiovascular risk: precision medicine for the individual patient or a better generalised approach at the population level?
15 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources